News
TLRY
2.650
-7.02%
-0.200
Tilray Brands Inc. Stock Slips 7.0%, Underperforms Market
Dow Jones · 17h ago
Does Marijuana Rescheduling Really Help Tilray's Stock?
The Motley Fool · 1d ago
Tilray Raises Its Guidance for the Year. Is the Stock Finally Headed on the Right Track?
The Motley Fool · 2d ago
Weekly Report: what happened at TLRY last week (1102-1106)?
Weekly Report · 2d ago
Which of These 5 Cannabis Stocks Has the Strongest Balance Sheet?
The Motley Fool · 3d ago
Tilray Brands Inc. Stock Rises 11.7%, Outperforms Market
Dow Jones · 6d ago
Tilray Stock Rises As Cannabis Giant Raises EBITDA Outlook, Targets Restructuring Across Canada
Benzinga · 11/02 15:17
Tilray narrows FY27 adjusted EBITDA view to $70M-$75M from $68M-$75M
TipRanks · 11/02 12:16
Tilray to consolidate Canadian cannabis operations
TipRanks · 11/02 12:10
Tilray Brands Plans To Consolidate Canadian Cannabis Operations, Transitioning Cultivation And Pre-Roll Production From Foss Facility In Fenwick, Ontario To Masson, Quebec And Cayuga, Ontario Facilities
Benzinga · 11/02 12:07
Press Release: Tilray Brands Announces Strategy -2-
Dow Jones · 11/02 12:00
Press Release: Tilray Brands Announces Strategy to Strengthen Canadian Cannabis Operations and Drive Profitable Growth
Dow Jones · 11/02 12:00
Weekly Report: what happened at TLRY last week (1026-1030)?
Weekly Report · 11/02 09:29
Forget U.S. Rescheduling: Tilray's 71% Growth in Europe Is the Story Investors Are Missing
The Motley Fool · 11/01 21:35
Tilray Just Posted Record Quarterly Revenue of $257 Million. So Why Did Its Cannabis Sales Shrink?
The Motley Fool · 11/01 07:20
Canopy Growth vs. Tilray Brands: Quarterly Revenue Scale and Consistency in Cannabis
The Motley Fool · 10/30 19:19
Tilray price target raised to $13 from $12 at Jefferies
TipRanks · 10/29 17:10
Tilray Targets $20M in Cost Savings as Part of U.S. Beverage Restructure
Dow Jones · 10/29 12:18
Tilray Brands Targets $20M In Annualized Cost Savings Through FY28; Plans Disposal Of Several Brewing And Warehouse Facilities; Reaffirms FY27 Adjusted EBITDA Guidance Of $68M-$75M
Benzinga · 10/29 11:29
*Tilray Brands Reaffirms Fiscal 2027 Adjusted EBITDA Guidance of $68M-$75M
Dow Jones · 10/29 11:06
More
Webull provides a variety of real-time TLRY stock news. You can receive the latest news about TILRAY BRANDS INC through multiple platforms. This information may help you make smarter investment decisions.
About TLRY
Tilray Brands, Inc. is a lifestyle consumer products company, which focuses on providing research-backed medical cannabis products to physicians, pharmacies, and patients around the world. The Company operates in four segments, which include cannabis operations, which encompasses the production, distribution, sale, co-manufacturing, and advisory services of both medical and adult-use cannabis. Beverage operations, which encompasses the production, marketing, and sale of beverage products. Distribution operations, which encompasses the purchase and resale of pharmaceutical products to customers, and Wellness products, which encompasses wellness and better-for-you foods and beverages. It offers a portfolio of brands and products across medical and adult-use cannabis, craft beer, spirits, beverages, and hemp foods. It also owns digital healthcare and patient engagement platform, focused on medical cannabis education, physician consultations, and patient support services.